H&R GmbH & Co. KGaA (DE:2HRA)
XETRA:2HRA
Want to see DE:2HRA full AI Analyst Report?
Top Page
H&R GmbH & Co. KGaA
(XETRA:2HRA)
Select Model
Select Model
Rating:51Neutral
Price Target:
€4.50
▲(3.21% Upside)
Action:ReiteratedDate:04/18/26
The score is held back primarily by the 2025 earnings deterioration and negative P/E, while improved cash flow and a manageable leverage profile provide partial support. Technically, momentum is weak with the price below longer-term moving averages, reinforcing a cautious overall view.
Positive Factors
Manageable leverage
A conservative capital structure with debt well below equity gives durable financial flexibility. Lower leverage reduces refinancing and solvency risk, supports strategic investment in specialty capacity, and cushions the company through commodity cycles, aiding long-term resilience.
Negative Factors
Profitability deterioration
The swing to a net loss and compressed operating margins in 2025 materially weakens the company's earnings power. If losses persist, retained earnings and reinvestment capacity will shrink, undermining R&D, specialty investments and long-term competitiveness versus peers.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage
A conservative capital structure with debt well below equity gives durable financial flexibility. Lower leverage reduces refinancing and solvency risk, supports strategic investment in specialty capacity, and cushions the company through commodity cycles, aiding long-term resilience.
Read all positive factors
H&R GmbH & Co. KGaA (2HRA) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€169.73M
Dividend Yield2.27%
Average Volume (3M)2.84K
Price to Earnings (P/E)―
Beta (1Y)0.39
Revenue Growth-7.18%
EPS Growth-465.28%
CountryDE
Employees1,705
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)-1.04
Shares Outstanding37,221,745
10 Day Avg. Volume1,415
30 Day Avg. Volume2,840
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.43
Price to Sales (P/S)0.13
P/FCF Ratio4.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.60Price Target Upside-17.43% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
EPS Forecast (FY)0.22
Revenue Forecast (FY)€1.32B
H&R GmbH & Co. KGaA Business Overview & Revenue Model
Company Description
H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment ma...
How the Company Makes Money
H&R makes money primarily by converting hydrocarbon feedstocks into higher-margin specialty and industrial products and selling them to business customers. Key revenue streams include: (1) Specialty chemicals: sales of chemical specialties derived...
H&R GmbH & Co. KGaA Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
63
Positive
Cash Flow
71
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.24B | 1.34B | 1.35B | 1.58B | 1.19B |
| Gross Profit | 120.37M | 121.06M | 115.78M | 155.57M | 143.55M |
| EBITDA | 69.19M | 91.69M | 88.33M | 123.76M | 131.35M |
| Net Income | -38.80M | 10.62M | 10.56M | 42.71M | 50.18M |
Balance Sheet | |||||
| Total Assets | 950.42M | 1.01B | 903.24M | 962.07M | 874.38M |
| Cash, Cash Equivalents and Short-Term Investments | 70.96M | 64.01M | 69.44M | 55.89M | 48.92M |
| Total Debt | 183.09M | 194.60M | 202.61M | 244.24M | 196.28M |
| Total Liabilities | 534.34M | 546.26M | 445.62M | 490.91M | 465.90M |
| Stockholders Equity | 375.64M | 426.86M | 413.02M | 423.64M | 362.60M |
Cash Flow | |||||
| Free Cash Flow | 37.53M | 15.23M | 61.42M | -32.04M | -11.59M |
| Operating Cash Flow | 93.14M | 70.24M | 119.07M | 37.98M | 37.42M |
| Investing Cash Flow | -57.73M | -54.45M | -56.26M | -72.46M | -48.56M |
| Financing Cash Flow | -23.57M | -25.80M | -46.94M | 41.51M | 2.48M |
H&R GmbH & Co. KGaA Technical Analysis
Positive
4.36
Price Trends
4.24
Positive
4.36
Negative
4.66
Negative
Market Momentum
-0.03
Negative
58.58
Neutral
57.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:2HRA, the sentiment is Positive. The current price of 4.36 is above the 20-day moving average (MA) of 4.08, above the 50-day MA of 4.24, and below the 200-day MA of 4.66, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 58.58 is Neutral, neither overbought nor oversold. The STOCH value of 57.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:2HRA.
H&R GmbH & Co. KGaA Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | €145.26M | 7.42 | 8.29% | 1.82% | -34.69% | -17.06% | |
62 Neutral | €47.17B | 12.41 | 5.24% | 5.16% | -11.46% | 137.39% | |
58 Neutral | €154.46M | 23.07 | 3.74% | 0.69% | -3.67% | 133.83% | |
56 Neutral | €534.90M | -3.43 | -16.03% | ― | -17.17% | 1.37% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | €169.73M | -1.04 | -9.55% | 2.27% | -7.18% | -465.28% |
* General Sector Average
DE:2HRA
H&R GmbH & Co. KGaA
4.50
0.58
14.80%
DE:AAG
Aumann AG
12.65
-0.55
-4.19%
DE:BAS
BASF SE
53.45
12.95
31.97%
DE:GSC1
GESCO AG
15.10
-1.65
-9.87%
DE:SGL
SGL Carbon
4.54
0.93
25.76%
DE:OEL
ADM Hamburg Aktiengesellschaft
230.00
28.32
14.04%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.